Bempedoic Acid And Ezetimibe
Brands: Nexlizet · Bempedoic Acid + Ezetimibe
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Brands: Nexlizet · Bempedoic Acid + Ezetimibe
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Esperion Therapeutics, Inc. | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint. — Recalling firm: Esperion — Nationwide in the USA
Failed dissolution specifications: below specification results at stability 12-month — Recalling firm: Esperion — Nationwide USA